Zhou Min, Wang Qinghua, Yang Rui, Zong Zhen, Huang Bowen, Chen Junjie, Bao Xin, Li Su, Shen Lanfeng, Dong Jianfeng, Zhao Xiaoqian, Chen Yu, Chen Daozhen
Department of Breast Surgery, Affiliated Women's Hospital of Jiangnan University, Wuxi Maternity and Child Health Care Hospital, Wuxi, Jiangsu, China.
Research Institute for Reproductive Health and Genetic Diseases, Affiliated Women's Hospital of Jiangnan University, Wuxi Maternity and Child Health Care Hospital, Wuxi, Jiangsu, China.
mSystems. 2025 Jul 22;10(7):e0027125. doi: 10.1128/msystems.00271-25. Epub 2025 Jun 23.
The consistency of the associations between the breast microbiome and breast cancer (BC) across various studies remains uncertain. Publicly accessible data sets from five BC studies, comprising 16S rRNA gene sequencing data from 161 BC tissues (BC_tissue), 195 BC adjacent non-cancerous tissues (BC_adjacent), and 451 normal breast tissues (normal_tissue), were retrieved from the European Nucleotide Archive. Overall, the microbial composition across the three breast tissue statuses was predominantly characterized by the phyla and , a distribution likely attributable to the fatty acid-rich environment of the breast tissue. Comparative analysis revealed that the relative abundances of the genera and were significantly increased in both BC_adjacent and normal_tissue compared to BC_tissue. This observation suggested a potential anticancer effect associated with these genera. Our analysis revealed a significant reduction in the abundance of and in BC tissues, which served as specific diagnostic features for BC. This finding was corroborated by our in-house data set ( = 28), which yielded similar conclusions. Subsequent and experiments verified the potential antitumor effects of supernatant in BC. In conclusion, our study highlighted the predictive capacity of microbial biomarkers in the onset of BC. Notably, specific bacterial species within the breast microbiome, such as and , exhibited potential as diagnostic markers for BC and may contribute significantly to antitumor activity. Nevertheless, the molecular mechanisms governing their interactions with cancer cells are not yet fully understood, necessitating further research to investigate their viability as targets for tumor prevention.IMPORTANCEAlthough a growing number of studies have highlighted the significant role of microorganisms in BC, there is a lack of consensus regarding the specific microbial genera consistently associated with breast cancer. While some studies have identified certain genera in the breast cancer environment, the results are often inconsistent and influenced by factors such as study design, population, or methodologies used. Through a comprehensive analysis of five publicly available breast cancer studies, along with validation from an in-house cohort, we found a significantly reduced abundance of and in BC tissues. and experiments demonstrated the antitumor effects of in BC. Understanding the antitumor mechanisms of in BC may provide potential avenues for developing novel therapeutic strategies for this disease.
不同研究中乳腺微生物群与乳腺癌(BC)之间关联的一致性仍不确定。从欧洲核苷酸档案库中检索了来自五项乳腺癌研究的公开数据集,包括161份乳腺癌组织(BC_tissue)、195份乳腺癌相邻非癌组织(BC_adjacent)和451份正常乳腺组织(normal_tissue)的16S rRNA基因测序数据。总体而言,三种乳腺组织状态下的微生物组成主要以门和门为特征,这种分布可能归因于乳腺组织富含脂肪酸的环境。比较分析显示,与BC_tissue相比,BC_adjacent和normal_tissue中属和属的相对丰度显著增加。这一观察结果表明这些属具有潜在的抗癌作用。我们的分析显示,BC组织中属和属的丰度显著降低,这可作为BC的特异性诊断特征。我们的内部数据集(=28)证实了这一发现,得出了类似的结论。随后的和实验验证了上清液在BC中的潜在抗肿瘤作用。总之,我们的研究突出了微生物生物标志物在BC发病中的预测能力。值得注意的是,乳腺微生物群中的特定细菌物种,如和,具有作为BC诊断标志物的潜力,可能对抗肿瘤活性有显著贡献。然而,它们与癌细胞相互作用的分子机制尚未完全了解,需要进一步研究以调查它们作为肿瘤预防靶点的可行性。重要性尽管越来越多的研究强调了微生物在BC中的重要作用,但对于始终与乳腺癌相关的特定微生物属缺乏共识。虽然一些研究在乳腺癌环境中鉴定出了某些属,但结果往往不一致,且受研究设计、人群或所用方法等因素影响。通过对五项公开的乳腺癌研究进行全面分析,并经内部队列验证,我们发现BC组织中属和属的丰度显著降低。和实验证明了在BC中的抗肿瘤作用。了解在BC中的抗肿瘤机制可能为开发针对该疾病的新型治疗策略提供潜在途径。